OPRX icon

OptimizeRx

94 hedge funds and large institutions have $102M invested in OptimizeRx in 2023 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 25 increasing their positions, 31 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more ownership

Funds ownership:

more funds holding in top 10

Funds holding in top 10:

less funds holding

Funds holding:

19% less repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 31

35% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 23

45% less capital invested

Capital invested by funds: $184M → $102M (-$82.2M)

Holders
94
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.81M
Puts
$403K
Net Calls
Net Calls Change

Top Buyers

1 +$4.78M
2 +$4.32M
3 +$2.62M
4
SC
Samjo Capital
New York
+$2.46M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$799K

Top Sellers

1 -$6.6M
2 -$6.55M
3 -$3.22M
4
Two Sigma Investments
Two Sigma Investments
New York
-$1.29M
5
Federated Hermes
Federated Hermes
Pennsylvania
-$973K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$654K
27
$560K
28
$549K
29
$499K
30
$419K
31
$413K
32
$382K
33
$372K
34
$349K
35
$345K
36
$331K
37
$317K
38
$289K
39
$274K
40
$268K
41
$232K
42
$225K
43
$215K
44
$213K
45
$200K
46
$194K
47
$183K
48
$182K
49
$178K
50
$175K